| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K66453893 |
| PharmacoGx | BRD-K66453893 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLST8 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.004 |
| mRNA | CEP135 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.004 |
| mRNA | RNF126 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.004 |
| mRNA | TRMT1L | CTRPv2 | pan-cancer | AAC | 0.091 | 0.004 |
| mRNA | TFE3 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.004 |
| mRNA | CENPC | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | SF3A3 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.004 |
| mRNA | KIAA1614 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.004 |
| mRNA | SPATS2L | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | TNC | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
